Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Disease Areas › Infectious Disease › Hardy Diagnostics to Distribute EliTechGroup's Urogenital Mycoplasma Detection System

Hardy Diagnostics to Distribute EliTechGroup's Urogenital Mycoplasma Detection System

Mar 15, 2019
|
staff reporter

NEW YORK (360Dx) – Hardy Diagnostics said on Friday it has become an authorized distributor of EliTechGroup's Mycofast US, a system for detecting, enumerating, and identifying genital Mycoplasma hominis and Ureaplasma urealyticum.

Financial and other terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

May
10
Featured Webinar

Predicting COVID-19 Severity: Leveraging the Host Immune Response to Identify High-Risk Patients and Improve Outcomes

Sponsored by
MeMed

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand. 

May
13
Featured Webinar

Limits of Detection Matter: New Challenges for SARS-CoV-2 Diagnostics and COVID-19 Patient Management

Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.

May
18
Featured Webinar

Put Your Money Where Your Mouth Is: Tracking and Attacking COVID-19 through State-Wide Saliva Surveillance

Sponsored by
Bio-Rad

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.  

What's Popular?

In Infectious Disease

  1. Biden Administration Funds $1B for COVID-19 Testing in Indian Country

  2. LGC Biosearch Technologies Gets FDA Emergency Use Authorization for SARS-CoV-2 Test

  3. With Luminex Acquisition, DiaSorin to Broaden MDx Portfolio, Expand US Presence

    Premium

  4. Labs Craft SARS-CoV-2 Variant Genotyping Assays for Screening, Surveillance

    Premium

  5. NIH Awards Qorvo Biotechnologies $24.4M for Rapid SARS-CoV-2 Antigen Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.